Target expression details
Target's General Information | |||||
---|---|---|---|---|---|
Target ID | T19760 | ||||
Target Name | Mixed lineage kinase 1 (MAP3K9) | ||||
Synonyms | PRKE1; Mitogen-activated protein kinase kinase kinase 9; MLK1 | ||||
Target Type | Clinical trial | ||||
Gene Name | MAP3K9 | ||||
Biochemical Class | Kinase | ||||
UniProt ID | M3K9_HUMAN | ||||
Target's Expression Profile in Disease Related Tissue between Patients and Normal People | |||||
Disease | Asthma | ||||
Example drug | CEP1347 | Phase 2/3 | [1], [2], [3] | ||
Tissue | Nasal and bronchial airway | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: 0.48 Z-score: 0.76 P-value: 9.49E-06 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
|||||
Target's Expression Profile across Various Tissues of Healthy Individual | |||||
References | |||||
REF 1 | Targeting the JNK signaling pathway for stroke and Parkinson's diseases therapy. Curr Drug Targets CNS Neurol Disord. 2005 Feb;4(1):63-7. | ||||
REF 2 | Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41. | ||||
REF 3 | NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.